We investigated the effects of VAE concomitant to Trastuzumab on proliferation, apoptosis induction, cell cycle progression and VEGF expression in a Her-2 overexpressing breast cancer cell line and could show concentration dependent additive effects. The gene discussed is ERBB2; the disease is breast cancer.